Fig. 4From: Metal-organic framework-modulated Fe3O4 composite au nanoparticles for antibacterial wound healing via synergistic peroxidase-like nanozymatic catalysis A The hemolytic rate of FMA NP-treated RBCs. B Viability of HUVECs treated with various concentrations of FMA NPs. C Viability of hepatocytes L-02 cells treated with various concentrations of FMA NPsBack to article page